Abstract
Background/objectives
Cowden syndrome (CS) is a rare genetic disorder caused by mutations in the PTEN gene associated with multisystem hamartomas and predisposition to malignancies. Although ocular involvement has been reported in case studies, systematic data are lacking. This study aimed to evaluate the prevalence, characteristics, and genotypic associations of ocular manifestations in CS patients within a large tertiary healthcare system.
Subjects/methods
We conducted a retrospective cohort study using the Mass General Brigham (MGB) Research Patient Data Registry, encompassing over 6 million patients from 2005 to 2024. Patients meeting clinical or genetic criteria for CS were identified. Ophthalmic findings, genotype–phenotype correlations, and clinical follow-up were extracted and analysed. A comprehensive literature review on CS-related ocular findings was performed to contextualize findings.
Results
Of the 6,026,276 patients in the RPDR, 144 patients carried the diagnostic codes for CS. After a manual review of all charts, 77 met the clinical or genetic criteria for CS. Of these, 17 (22%) underwent ophthalmologic evaluation, and 4 (5%) exhibited CS-related ocular findings, including retinal hamartoma, eyelid hemangioma, trichilemmoma, and a peripapillary hamartoma-like lesion. Most patients maintained excellent vision over a median follow-up of four and a half years. Retinal imaging was limited, with OCT and OCTA available in only one case. Genotype analysis revealed that truncating PTEN variants were more likely associated with central nervous system involvement. Literature review identified a broader spectrum of ocular anomalies in CS, underscoring phenotypic variability.
Conclusions
The prevalence of CS in a large US tertiary setting is 1.28/100,000. Ocular manifestations in CS are rare and typically benign, with preserved vision in most cases. However, variability in presentation and mutation types may influence the risk. Notably, three of the four patients with ocular findings, possibly associated with CS, carried truncating variants. The fourth was PTEN-positive, but the specific variant was not retrievable. Multicentre studies are warranted to better define the full ocular phenotype of CS and to guide screening recommendations.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others
Data availability
The data supporting the findings of this study are available from the corresponding author upon reasonable request.
References
Lachlan KL, Lucassen AM, Bunyan D, Temple IK. Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet. 2007;44:579–85.
Lloyd KM, Dennis M. Cowden’s disease: a possible new symptom complex with multiple system involvement. Ann Intern Med. 1963;58:136–42.
Blumenthal GM, Dennis PA. PTEN hamartoma tumor syndromes. Eur J Hum Genet. 2008;16:1289–300.
Nelen M. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet. 1997;6:1383–7.
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst. 2013;105:1607–16.
Nelen MR, Kremer H, Konings IB, Schoute F, Essen AJV, Koch R, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype–phenotype correlations. Eur J Hum Genet. 1999;7:267–73.
Moussa G, Bassilious K, Mathews, N. A novel excel sheet conversion tool from Snellen fraction to LogMAR including ‘counting fingers’, ‘hand movement’, ‘light perception’ and ‘no light perception’ and focused review of literature of low visual acuity reference values. Acta Ophthalmol. 2021;99. https://onlinelibrary.wiley.com/doi/10.1111/aos.14659.
Marsh DJ, Kum JB, Lunetta KL, Bennett MJ, Gorlin RJ, Ahmed SF, et al. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Hum Mol Genet. 1999;8:1461–72.
Mester JL, Ghosh R, Pesaran T, Huether R, Karam R, Hruska KS, et al. Gene-specific criteria for PTEN variant curation: recommendations from the ClinGen PTEN expert panel. Hum Mutat. 2018;39:1581–92.
Virtanen P, Gommers R, Oliphant TE, Haberland M, Reddy T, Cournapeau D, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods. 2020;17:261–72.
McKinney, W. Data structures for statistical computing in Python. SciPy Proceedings. 2010:56–61, https://doi.curvenote.com/10.25080/Majora-92bf1922-00a.
Anaconda Software Distribution. Anaconda Inc.; 2025. Available from: https://docs.anaconda.com/anaconda/.
Weary PE, Gorlin RJ, Gentry WC, Comer JE, Greer KE. Multiple hamartoma syndrome (Cowden’s disease). Arch Dermatol. 1972;106:682–90.
Nuss DD, Aeling JL, Clemons DE, Weber WN. Multiple hamartoma syndrome (Cowden’s disease). Arch Dermatol. 1978;114:743–6.
Starink ThM. Cowden’s disease: analysis of fourteen new cases. J Am Acad Dermatol. 1984;11:1127–41.
Bardenstein DS, McLean IW, Nerney J, Boatwright R. Cowden’s disease. Ophthalmology. 1988;95:1038–41.
Wells GB, Lasner TM, Yousem DM, Zager EL. Lhermitte-Duclos disease and Cowden’s syndrome in an adolescent patient: case report. J Neurosurg. 1994;81:133–6.
Gicquel JJ, Vabres P, Bonneau D, Mercié M, Handiri L, Dighiero P. Retinal angioma in a patient with Cowden disease. Am J Ophthalmol. 2003;135:400–2.
Venturini G, Moulin AP, Deprez M, Uffer S, Bottani A, Zografos L, et al. Clinicopathologic and molecular analysis of a choroidal pigmented schwannoma in the context of a PTEN hamartoma tumor syndrome. Ophthalmology. 2012;119:857–64.
Mansoor Q, Steel DHW. Proliferative retinopathy in Cowden syndrome. BMJ Case Rep. 2012;2012:bcr1120115273
Sbordone S, Savastano A, Savastano MC, Romano V, Bifani M, Savastano S. Corneal confocal microscopy anomalies associated with Cowden syndrome: a case report. Case Rep Ophthalmol. 2013;4:76–80.
Suaiti L, Al-Haseni A, Lee H, Sahni D. Iris mammillations in a pair of twins with Cowden syndrome. JAAD Case Rep. 2016;2:323–5.
DeParis SW, Bloomer M, Han Y, Vagefi MR, Shieh JTC, Solomon DA, et al. Uveal ganglioneuroma due to germline PTEN mutation (Cowden Syndrome) presenting as unilateral infantile glaucoma. Ocul Oncol Pathol. 2017;3:122–8.
Cavaillé M, Ponelle-Chachuat F, Uhrhammer N, Viala S, Gay-Bellile M, Privat M, et al. Early onset multiple primary tumors in atypical presentation of Cowden syndrome identified by whole-exome-sequencing. Front Genet. 2018;9:353.
Sweeney AR, Shetlar DJ. Multiple eyelid neoplasms in Cowden syndrome. Ophthal Plast Reconstr Surg. 2020;36:e161
Wu F, Mukai S. Refractory choroidal neovascularization in a patient with pseudoxanthoma elasticum and Cowden syndrome. J Vitreoretin Dis. 2023;7:70–3.
Cohen DC, Tsui JC, Scoles D. Congenital retinal macrovessel and cavernous hemangioma in Cowden syndrome: a case report and review of literature. Retin Cases Brief Rep. 2024;18:702–6.
Liu C, Li G, Chen R, Yang X, Zhao X, Zhao H. A novel PTEN gene promoter mutation and untypical Cowden syndrome. Chin J Cancer Res. 2013;25:306–11.
Funding
The study is funded by Yeatts and Loeffler Family funds.
Author information
Authors and Affiliations
Contributions
K.G. Baroutis: Collected and analyzed the data, validated the study and drafted the manuscript. S. Hoyek: Validated the data and contributed to manuscript revisions. V.S.M.C. Correa: Validated the data and contributed to manuscript revisions. D.P. Ntentakis: Validated the data and contributed to manuscript revisions. N.A. Patel: Validated the data and contributed to manuscript revisions. D.G. Vavvas: Supervised the project, provided guidance, and approved the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Baroutis, K.G., Hoyek, S., Correa, V.S.M.C. et al. Ophthalmological manifestations in a cohort of Cowden syndrome patients in a large tertiary healthcare system. Eye 39, 2926–2932 (2025). https://doi.org/10.1038/s41433-025-03966-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-025-03966-0


